Literature DB >> 24450691

Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients.

Annette Wacker-Gußmann1, Katharina Bühren, Caroline Schultheiss, Siegmund Lorenz Braun, Sharon Page, Bernd Saugel, Sebastian Schmid, Sebastian Mair, Albert Schoemig, Roland M Schmid, Wolfgang Huber.   

Abstract

OBJECTIVE: Preexisting renal impairment is a risk factor for contrast-induced nephropathy (CIN). In patients with creatinine in the upper normal level, cystatin C might be a more sensitive predictor of CIN than creatinine. Therefore, in this study, we investigated the usefulness of cystatin C to predict CIN. SUBJECTS AND METHODS: In 400 consecutive patients with creatinine baseline levels between 0.8 and 1.3 mg/dL undergoing coronary angiography (n = 200) or CT (n = 200), baseline values of cystatin C, creatinine, blood urea nitrogen (BUN) and risk factors of CIN were determined. Creatinine was also assessed 24 and 48 hours after contrast administration.
RESULTS: Creatinine significantly (p < 0.001) increased after 24 hours and 48 hours compared with baseline (1.06 ± 0.28 and 1.07 ± 0.28 vs 0.99 ± 0.18 mg/dL). Fifty-three of 373 evaluable patients (14.2%) had an increase in creatinine of ≥ 25% or ≥ 0.5 mg/dL within 48 hours. CIN according to this definition was significantly more frequent after intraarterial contrast administration (38/190, 20%) compared with IV contrast administration (15/183, 8.2%; p = 0.001). CIN was predicted by baseline cystatin C (area under the receiver operating characteristic [ROC] curve [AUC], 0.715; p < 0.001), whereas creatinine, creatinine clearance, and BUN were not predictive. The best predictive capabilities were provided by cystatin C/creatinine-ratio (AUC, 0.826; p < 0.001). Multivariate regression analysis showed that intraarterial contrast administration (p = 0.002) and higher baseline cystatin C (p < 0.001) combined with low creatinine (p = 0.044) were independently associated with higher increases in creatinine within 48 hours after contrast administration.
CONCLUSION: CIN in patients with creatinine within the upper normal range is significantly more frequent after intraarterial than after IV contrast administration. In these patients, renal impairment after contrast administration is independently predicted by cystatin C and cystatin C/creatinine-ratio, whereas BUN and creatinine were not predictive.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24450691     DOI: 10.2214/AJR.13.10688

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  Serum cystatin c is not superior to serum creatinine for early diagnosis of contrast-induced nephropathy in patients who underwent angiography.

Authors:  Qian Xu; Na-Na Wang; Shao-Bin Duan; Na Liu; Rong Lei; Wei Cheng; Shun-Ke Zhou
Journal:  J Clin Lab Anal       Date:  2016-11-29       Impact factor: 2.352

2.  Comparison of Carvedilol and Metoprolol for Preventing Contrast-Induced Nephropathy after Coronary Angiography.

Authors:  Mustafa Yılmaz; Alp Aydınalp; Kaan Okyay; Abdullah Tekin; Uğur Abbas Bal; Nilüfer Bayraktar; Aylin Yıldırır; Haldun Müderrisoğlu
Journal:  Cardiorenal Med       Date:  2015-05-30       Impact factor: 2.041

3.  Elevation of preoperative cystatin C as an early predictor of contrast-induced nephropathy in patients receiving percutaneous coronary intervention.

Authors:  Guoqiang Gu; Ningning Yu; Yaqing Zhou; Wei Cui
Journal:  Singapore Med J       Date:  2022-08       Impact factor: 3.331

4.  Safe contrast volumes for preventing contrast-induced nephropathy in elderly patients with relatively normal renal function during percutaneous coronary intervention.

Authors:  Yong Liu; Yuan-Hui Liu; Ji-Yan Chen; Ning Tan; Ying-Ling Zhou; Chong-Yang Duan; Dan-Qing Yu; Nian-Jin Xie; Hua-Long Li; Ping-Yan Chen
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

5.  Biomarker response to contrast administration in diabetic and nondiabetic patients following coronary angiography.

Authors:  V L Ashalatha; A R Bitla; V S Kumar; D Rajasekhar; M M Suchitra; A Y Lakshmi; P V L N S Rao
Journal:  Indian J Nephrol       Date:  2017 Jan-Feb

6.  Sodium Bicarbonate Prevents Contrast-Induced Nephropathy in Addition to Theophylline: A Randomized Controlled Trial.

Authors:  Wolfgang Huber; Toni Huber; Stephan Baum; Michael Franzen; Christian Schmidt; Thomas Stadlbauer; Analena Beitz; Roland M Schmid; Sebastian Schmid
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.